Growth axis
Modified GRF (1–29)
CJC-1295 no DAC / Mod GRF 1-29 / Modified GRF 1-29
- Peptide length
- 29 amino acids
Modified GHRH fragment without DAC
Research contextPredominantly preclinical
Read the linked studies for their methods and limitations.
A name used for modified GHRH (1–29) preparations lacking the albumin-binding drug-affinity complex of CJC-1295.
- Family
- GHRH analog
- Research frame
- GHRH receptor pathway
- Molecular format
- Modified GHRH fragment without DAC
Read the evidence
The published long-acting CJC-1295 human trial is not evidence for a no-DAC product. Resolve the exact substitutions before matching a source.
Resolve the identity
Require a complete sequence, stereochemistry and terminal form. Market use of “CJC-1295 no DAC” is not a standardized structural specification.